NCT03785964 2025-01-31DeFiSpringWorks Therapeutics, Inc.Phase 3 Completed142 enrolled 21 charts 1 FDA
NCT01981551 2024-02-06Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive FibromatosisNational Institutes of Health Clinical Center (CC)Phase 2 Completed17 enrolled 14 charts